Selecting informative patients for phase 2 progressive trials in MS: Design considerations for phase 2 clinical trials in progressive MS

Koch, M. W., Camara-Lemarroy, C., Strijbis, E., Mostert, J., Leavitt, V. M., Repovic, P., Bowen, J. D., Comtois, J., Uitdehaag, B., & Cutter, G. (2024). Selecting informative patients for phase 2 progressive trials in MS: Design considerations for phase 2 clinical trials in progressive MS. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585241274620
Authors:
Marcus W Koch
Carlos Camara-Lemarroy
Eva Strijbis
Jop Mostert
Victoria M Leavitt
Pavle Repovic
James D Bowen
Jacynthe Comtois
Bernard Uitdehaag
Gary Cutter
Affiliated Authors:
Victoria M Leavitt
Columbia Affiliation:
Author Keywords:
clinical trial
atrophy
disease modifying therapies
outcome measurement
progressive
elink
Publication Type:
Article
Unique ID:
10.1177/13524585241274620
PMID:
39245930
DOI:
10.1177/13524585241274620
Journal:
Multiple Sclerosis Journal
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: